<DOC>
	<DOCNO>NCT02916901</DOCNO>
	<brief_summary>The purpose study determine influence CKD-519 24-h ambulatory blood pressure oral administration healthy adult volunteer .</brief_summary>
	<brief_title>Study Investigate Influence CKD-519 24-h Ambulatory Blood Pressure Healthy Adult Volunteers</brief_title>
	<detailed_description>A randomized , double-blind , placebo-controlled , multiple dosing , cross-over phase I clinical trial investigate effect CKD-519 24-h ambulatory blood pressure oral administration healthy adult volunteer .</detailed_description>
	<criteria>1 . Between 19 age 55 age healthy adult 2 . Body weight 55kg male , 50kg female 3 . Body Mass Index 18.5 25 ( body mass index=kg/m2 ) 4 . If female , must include one among item The menopause ( natural menses least 2 year ) Surgical Infertility ( hysterectomy bilateral oophorectomy , tubal ligation method infertility condition 5 . If men sexual life woman childbearing age , Necessarily agree use condom sperm donation two month clinical trial final dosage investigational product 6 . Those fully understand clinical trial enough hearing , decide join clinical trial comply precaution write consent . 1 . Have clinically significant disease hepatobiliary system ( severe hepatic impairment , etc ) , kidney ( severe renal impairment , etc ) , nervous system , immune system , respiratory system , endocrine system , hematooncology disease , cardiovascular system ( heart failure , etc ) mental illness , history mental disease . 2 . Have gastrointestinal disease history effect drug absorption ( Crohn 's disease , ulcer , etc . ) surgery ( except simple appendectomy hernia surgery ) 3 . Hypersensitivity reaction clinically significant hypersensitivity reaction history drug additives . 4 . An impossible one participate clinical trial include screen test ( medical history taking , BP , 12lead ECG , physical examination , blood &amp; urine laboratory test result ) 28 day take investigational Products . 5 . Defined follow laboratory parameter AST , ALT &gt; 1.25 upper limit normal range Total bilirubin &gt; 1.5 upper limit normal range CPK &gt; 1.5 upper limit normal range eGFR ( use MDRD method ) &lt; 60mL/min/1.73m2 6 . Sitting SBP &gt; 140mmHg &lt; 90mmHg , sit DBP &gt; 90mmHg &lt; 60mmHg , 5 minute break . 7 . The difference DBP &gt; 10mmHg SBP &gt; 20mmHg screening period 8 . Drug abuse history drug abuse show positive urine drug test . 9 . Pregnant lactating woman . 10 . A heavy caffeine consumer ( caffeine &gt; 5 cups/day ) , alcohol consumer ( alcohol &gt; 210g/week ) , 11. smoker ( except one stop smoke 90days begin study treatment ) 12 . Subject take ethical drug herbal medicine within 14 day , OTC within 7 day begin study treatment investigator determine take drug affect study could affect safety subject . 13 . Subject take inhibitor inducer drug metabolize enzyme ( Barbiturates etc . ) within 30 day . 14 . Taking food contain grapefruit within 7 day begin study treatment ( ex . Drinking contain grapefruit 1L per day within 7 day begin study treatment ) 15 . Subject treat investigational drug within 90 day begin study treatment 16 . Previously donate whole blood within 60 day component blood within 30 day . 17 . Positive Serology test ( Hepatitis B , Hepatitis C , HIV ) 18 . An impossible one participant clinical trial investigator 's decision include laboratory test result another reason</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Dyslipidemia</keyword>
	<keyword>CKD-519</keyword>
	<keyword>CETP inhibitor</keyword>
	<keyword>ABPM</keyword>
</DOC>